Cargando…
Reimbursement for therapeutic apheresis devices and procedures for using the healthcare insurance system in Japan
The aim of this paper was to explain the insurance coverage status of therapeutic apheresis (excluding CHDF) in Japan, alongside the social system of medical reimbursement and concerns regarding the future sustainability of the healthcare system. Insurance schemes and premiums differed for individua...
Autores principales: | Kusaoi, Makio, Murayama, Go, Tamura, Naoto, Yamaji, Ken |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540553/ https://www.ncbi.nlm.nih.gov/pubmed/32567164 http://dx.doi.org/10.1111/1744-9987.13550 |
Ejemplares similares
-
Critical role of lectin pathway mediated by MBL-associated serine proteases in complement activation for the pathogenesis in systemic lupus erythematosus
por: Asanuma, Yuko, et al.
Publicado: (2023) -
Regarding: “Insurance Reimbursement for Complementary Healthcare Services”
por: Whedon, James M.
Publicado: (2018) -
Reimbursement pricing for new medical devices in Japan: Is the evaluation of innovation appropriate?
por: Tamura, Makoto, et al.
Publicado: (2018) -
Effect of Plasma Exchange in Thyroid Storm With Consideration of Its Distribution Into the Extravascular Space
por: Shinohara, Mai, et al.
Publicado: (2020) -
Physician pricing and health insurance reimbursement
por: Yett, Donald E., et al.
Publicado: (1983)